Using machine learning algorithms to optimize treatment with high-cost biologics in a national cohort of patients with inflammatory bowel disease
{{output}}
Objectives: Prediction models using statistical or machine learning (ML) approaches can enhance clinical decision support tools. Infliximab (IFX), a biologic with a newly introduced biosimilar for Crohn's disease (CD) and ulcera... ...
